Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hib-MenC Booster with Priorix in Toddlers
NCT00263653Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2005
- Primary completion
- Mar 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Hib-MenC-TT in Haemophilus influenzae type b infection (Hib), meningococcal serogroup C disease, sponsored by GSK. Started Mar 2005; status: completed.
02
Drugs
Hib-MenC-TT
03
Conditions
Haemophilus influenzae type b infection (Hib)meningococcal serogroup C disease
Beyond the preview
Go deeper on NCT00263653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00263653.